Payer Perspectives in Vitiligo: Optimizing Patient Outcomes With Novel Therapeutic Approaches

A panel of experts discuss the diagnosis and pathophysiology of vitiligo.

Chesahna Kindred, MD, MBA, FAAD, and Renata Block, PA-C, review areas of the body that are typically affected, and are more problematic to manage, in patients with vitiligo. Comorbidities that put certain patients at higher risk than others are also discussed.

Gary M. Owens, MD, discusses the economic costs associated with vitiligo and the impact this disease has had on the US health care system in general.

Renata Block, PA-C, analyzes a study on how vitiligo affects different socioeconomic groups disproportionately.